NSN 6505-01-371-7070
Part Details | USP RANITIDINE IN SODIUM CHLORIDE INJECTION
6505-01-371-7070
Alternate Parts: 23781, 6505NCM116383, ZANTAC INJECTION PREMIXED, ZANTAC, NDC00173044100, NDC00173-0441-00, 6505-01-371-7070, 01-371-7070, 6505013717070, 013717070
Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
---|---|---|---|
65 | FEB 21, 1993 | 01-371-7070 | 47548 ( RANITIDINE IN SODIUM CHLORIDE INJECTION, USP ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-371-7070
Part Number | Cage Code | Manufacturer |
---|---|---|
23781 | 89875 | DEFENSE LOGISTICS AGENCYDIRECTORATE OF MEDICAL MATERIEL |
6505NCM116383 | 64616 | DEFENSE MEDICAL STANDARDIZATIONBOARD |
ZANTAC INJECTION PREMIXED | 34006 | GLAXO WELLCOME INC |
ZANTAC | 34006 | GLAXO WELLCOME INC |
NDC00173-0441-00 | 34006 | GLAXO WELLCOME INC |
Technical Data | NSN 6505-01-371-7070
Characteristic | Specifications |
---|---|
PRIMARY CONTAINER TYPE | BAG WITH HANGING DEVICE, PLASTIC |
PRIMARY CONTAINER CONTENT QUANTITY | 50.000 MILLILITERS |
ACTIVE MEDICAMENT MEDICINAL STRENGTH | BZ50.000 MILLIGRAMS RANITIDINE |
ADMINISTRATION | INTRAVENOUS |
TOTAL PRIMARY CONTAINER QUANTITY | 24 |
SPECIAL FEATURES | PREMIXED IN 0.45 PCT. SODIUM CHLORIDE; SINGLE DOSE BAG; STORE BETWEEN 2 AND 25 DEG C (36 AND 77 DEG F); CONTAINS NO PRESERVATIVES; PROTECT FROM LIGHT |
THERAPEUTIC EQUIVALENT | ZANTAC BY GLAXO |
SUPPLEMENTARY FEATURES | FOR USE W/INTRAVENOUS ADMINISTRATION SETS |
PART NAME ASSIGNED BY CONTROLLING AGENCY | RANITIDINE IN SODIUM CHLORIDE INJECTION USP 50ML BAG 24S |